Hot and cold tumors: Immunological features and the therapeutic strategies DOI Creative Commons
Lianjie Wang, Hui Geng, Yujie Liu

et al.

MedComm, Journal Year: 2023, Volume and Issue: 4(5)

Published: Aug. 26, 2023

Abstract The “hotness” or “coldness” of the tumors are determined by information cancer cells themselves, tumor immune characteristics, microenvironment, and signaling mechanisms, which key factors affecting patients’ clinical efficacy. switch mechanism its corresponding pathological characteristics treatment strategies frontier hot spot treatment. How to distinguish effectively clarify causes, microenvironment state, very important for response efficacy treatments. Starting from concept cold tumor, this review systematically summarized molecular influencing factors, therapeutic “hot tumors,” analyzed immunophenotypes, pathways, markers that contribute tumors” in details. Different “cold based on were with drug targets proteins tumors.” Furthermore, combines different traditional medicine modern medicine, provide a basis guidance decision‐making

Language: Английский

Hepatocellular carcinoma DOI Open Access
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva

et al.

Nature Reviews Disease Primers, Journal Year: 2021, Volume and Issue: 7(1)

Published: Jan. 21, 2021

Language: Английский

Citations

4472

Tertiary lymphoid structures in the era of cancer immunotherapy DOI
Catherine Sautès‐Fridman, Florent Petitprez, Julien Caldéraro

et al.

Nature reviews. Cancer, Journal Year: 2019, Volume and Issue: 19(6), P. 307 - 325

Published: May 15, 2019

Language: Английский

Citations

1303

Immunotherapies for hepatocellular carcinoma DOI
Josep M. Llovet, Florian Castet, Mathias Heikenwälder

et al.

Nature Reviews Clinical Oncology, Journal Year: 2021, Volume and Issue: 19(3), P. 151 - 172

Published: Nov. 11, 2021

Language: Английский

Citations

1170

Tertiary lymphoid structures in cancer DOI
Ton N. Schumacher, Daniela S. Thommen

Science, Journal Year: 2022, Volume and Issue: 375(6576)

Published: Jan. 6, 2022

Ectopic lymphoid aggregates, termed tertiary structures (TLSs), are formed in numerous cancer types, and, with few exceptions, their presence is associated superior prognosis and response to immunotherapy. In spite of presumed importance, the triggers that lead TLS formation tissue contribution these intratumoral immune responses remain incompletely understood. Here, we discuss present knowledge on TLSs cancer, focusing (i) drivers formation, (ii) function antitumor response, (iii) potential as therapeutic targets human cancers.

Language: Английский

Citations

649

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer DOI Creative Commons
Maxime Meylan, Florent Petitprez, Étienne Becht

et al.

Immunity, Journal Year: 2022, Volume and Issue: 55(3), P. 527 - 541.e5

Published: Feb. 28, 2022

Language: Английский

Citations

441

Molecular and histological correlations in liver cancer DOI Creative Commons
Julien Caldéraro, Marianne Ziol, Valérie Paradis

et al.

Journal of Hepatology, Journal Year: 2019, Volume and Issue: 71(3), P. 616 - 630

Published: June 10, 2019

Language: Английский

Citations

435

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome DOI
Wolf H. Fridman, Maxime Meylan, Florent Petitprez

et al.

Nature Reviews Clinical Oncology, Journal Year: 2022, Volume and Issue: 19(7), P. 441 - 457

Published: April 1, 2022

Language: Английский

Citations

398

Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications DOI
Terence K. Lee, Xin‐Yuan Guan, Stephanie Ma

et al.

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2021, Volume and Issue: 19(1), P. 26 - 44

Published: Sept. 9, 2021

Language: Английский

Citations

320

Intratumoral heterogeneity and clonal evolution in liver cancer DOI Creative Commons
Bojan Losic, Amanda J. Craig, Carlos Villacorta-Martín

et al.

Nature Communications, Journal Year: 2020, Volume and Issue: 11(1)

Published: Jan. 15, 2020

Abstract Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally immune and treatment mediated. We integrate RNA-seq, DNA sequencing, TCR-seq SNP array data across multiple regions liver cancer specimens to map spatio-temporal interactions between cells. investigate how these reflect intra-tumor heterogeneity (ITH) by correlating regional neo-epitope viral antigen burden with the adaptive response. Regional expression passenger mutations dominantly recruits responses as opposed hepatitis B virus cancer-testis antigens. detect clonal expansion system in distant same tumor. An ITH-based gene signature improves single-biopsy patient survival predictions an survey 38,553 single cells 7 2 patients further reveals cancer. These quantify transcriptomic ITH components HCC interact during evolution.

Language: Английский

Citations

298

A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma DOI Creative Commons
Yiming Lu, Aiqing Yang,

Cheng Quan

et al.

Nature Communications, Journal Year: 2022, Volume and Issue: 13(1)

Published: Aug. 6, 2022

Abstract Hepatocellular carcinoma (HCC) represents a paradigm of the relation between tumor microenvironment (TME) and development. Here, we generate single-cell atlas multicellular ecosystem HCC from four tissue sites. We show enrichment central memory T cells (T CM ) in early tertiary lymphoid structures (E-TLSs) assess relationships chronic HBV/HCV infection cell infiltration exhaustion. find MMP9 + macrophages to be terminally differentiated tumor-associated (TAMs) PPARγ pivotal transcription factor driving their differentiation. also characterize heterogeneous subpopulations malignant hepatocytes multifaceted functions shaping immune HCC. Finally, identify seven microenvironment-based subtypes that can predict prognosis patients. Collectively, this large-scale deepens our understanding microenvironment, which might facilitate development new therapy strategies for malignancy.

Language: Английский

Citations

249